Inhibitory effect of osthole on alcohol-induced fatty liver in mice

Digestive and Liver Disease

Volumn 41, Issue 2, 2009, Pages 127-133

  Sun, F ^a   Xie, M L ^a   Zhu, L J ^a   Xue, J ^a   Gu, Z L ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Alcoholic fatty liver; Lipid accumulation; Mice; Osthole

Indexed keywords

GLUTATHIONE; MALONALDEHYDE; OSTHOLE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID STORAGE; LIVER WEIGHT; MALE; MORNING DOSAGE; MOUSE; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL; WINE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; COUMARINS; DISEASE MODELS, ANIMAL; FATTY ACIDS, NONESTERIFIED; FATTY LIVER, ALCOHOLIC; GLUTATHIONE; LIPID METABOLISM; LIVER; MALE; MALONDIALDEHYDE; MICE; ORGAN SIZE; SUPEROXIDE DISMUTASE; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149161248     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.01.011     Document Type: Article

References (27)

1. Crab D.W. Recent developments in alcoholism: the liver. Recent Dev Alcohol 11 (1993) 207-230
2. Diehl A.M. Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis. Alcohol Clin Exp Res 25 (2001) 8S-14S
3. Martinez F., Aril E.R., Earnest D.L., and Watson R.R. Ethanol and cytokine secretion. Alcohol 9 (1992) 455-458
4. Watanabe N., Suzuki J., and Kobayashi Y. Role of calcium in tumor necrosis factor α produced by activated macrophages. J Biochem 120 (1996) 1190-1195
5. Iimuro Y., Gallucci R.M., Luster M.I., Kono H., and Thurman R.G. Antibodies to tumor necrosis factor-α attenuate hepatic necrosis and inflammation due to chronic exposure to ethanol in the rat. Hepatology 26 (1997) 1530-1537
6. Yin M., Wheeler M.D., Kono H., Bradford B.U., Gallucci R.M., Luster M.I., et al. Essential role of tumor necrosis factor-α in alcohol-induced liver injury in mice. Gastroenterology 117 (1999) 942-952
7. Lian Q.S. Progress in study of chemical constituents and pharmacological effects of the fruits of Cnidium monnieri. Chin Med Mater 26 (2003) 141-144
8. Liu J.X., Zhang W.P., Zhou L., Wang X.R., and Lian Q.S. Anti-inflammatory effect and mechanism of osthole in rats. J Chin Med Mater 28 (2005) 1002-1006
9. Experiment study on anti-oxidation effect of osthole. Chin Tradit Patent Med 2005;27:488-9.
10. Zhang Q., Qin L., He W., Puyvelde L.V., Maes D., Zheng H., et al. Coumarins from Cnidium monnieri and their antiosteoporotic activity. Planta Med 73 (2007) 13-19
11. Okamoto T., Kawasaki T., and Hino O. Osthole prevents anti-fas antibody-induced hepatitis in mice by affecting the caspase-3-mediated apoptotic pathway. Biochem Pharmacol 65 (2003) 677-681
12. Zhou J., Cheng W.X., and Xu Y.H. Experimental study on anti-tumour effect of osthole extracted from the fruits of Cnidium monnieri (L.) Cusson. Zhejiang J Integr Tradit West Med 12 (2002) 76-78
13. Kuo P.L., Hsu Y.L., Chang C.H., and Chang J.K. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells. J Pharmacol Exp Ther 314 (2005) 1290-1299
14. Song F., Xie M.L., Zhu L.J., Zhang K.P., Xue J., and Gu Z.L. Experimental study of osthole on treatment of hyperlipidemic and alcoholic fatty liver in animals. World J Gastroenterol 12 (2006) 4359-4363
15. Zhang Y., Xie M.L., Xue J., and Gu Z.L. Osthole improves fat milk-induced fatty liver in rats: modulation of hepatic PPAR-alpha/gammar-mediated lipogenic gene expression. Planta Med 73 (2007) 718-724
16. Zhao M., Yang X.F., and Huang J.M. Study on liver injury model induced by alcohol. Chin J Public Health 21 (2005) 1101-1102
17. Guo J.Y., Wang Q.J., and Wu J.H. Studies on the protective effect of saponins from polygala aureocauda on animal models of liver injury. Chin J Nat Med 4 (2006) 303-307
18. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226 (1957) 497-509
19. Diehl A.M. Liver disease in alcohol abusers: clinical perspective. Alcohol 27 (2002) 7-11
20. Pessayre D., Berson A., Fromenty B., and Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis 21 (2001) 57-69
21. Rivera C.A., Bradford B.U., Seabra V., and Thurman R.G. Role of endotoxin in the hypermetabolic state after acute ethanol exposure. Am J Physiol Gastrointest Liver Physiol 275 (1998) 1252-1258
22. You M., Fischer M., Deeg M.A., and Crabb D.W. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 277 (2002) 29342-29347
23. You M., and Crab D.W. Molecular mechanisms of alcoholic fatty liver: role of sterol regulatory element-binding proteins. Alcohol 34 (2004) 39-43
24. Nanji A.A., Jokelainen K., Rahemtulla A., Miao L., Fogt F., Matsumoto H., et al. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 30 (1999) 934-943
25. Uchimura K., Nakamuta M., Enjoji M., Irie T., Sugimoto R., Muta T., et al. Activation of retinoic X receptor and peroxisome proliferator activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells. Hepatology 33 (2001) 91-99
26. Enomoto N., Takei Y., Hirose M., Konno A., Shibuya T., Matsuyama S., et al. Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-γ, pioglitazone. J Pharmacol Exp Ther 306 (2003) 846-854
27. Zhang Y., Xie M.L., Zhu L.J., and Gu Z.L. Therapeutic effect of osthole on hyperlipidemic fatty liver in rats. Acta Pharmacol Sin 28 (2007) 398-403